A Study to Evaluate the Pharmacodynamic Activity of E2082 in Adult Participants With Photosensitive Epilepsy
Status:
Terminated
Trial end date:
2019-06-18
Target enrollment:
Participant gender:
Summary
The primary purpose of the study is to assess pharmacodynamic (PD) activity of E2082 as
measured by suppression of epileptic photoparoxysmal response (PPR) in the participant's most
sensitive eye condition in participants with photosensitive epilepsy, compared to placebo.